- Home
- ZNB vs BDRX Comparison
ZNB vs BDRX Comparison
Compare ZNB & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZNB | BDRX |
|---|---|---|
| Founded | 2002 | 2000 |
| Country | China | United Kingdom |
| Employees | N/A | N/A |
| Industry | Engineering & Construction | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4M | 1.6M |
| IPO Year | 2018 | 2015 |
Fundamental Metrics
Financial Performance| Metric | ZNB | BDRX |
|---|---|---|
| Price | $1.34 | $1.16 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 314.9K | ★ 7.2M |
| Earning Date | 11-12-2025 | 09-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.10 | $0.60 |
| 52 Week High | $9.78 | $11.88 |
Technical Indicators
Market Signals| Indicator | ZNB | BDRX |
|---|---|---|
| Relative Strength Index (RSI) | 36.80 | 54.95 |
| Support Level | $1.29 | $1.03 |
| Resistance Level | $1.90 | $1.50 |
| Average True Range (ATR) | 0.12 | 0.17 |
| MACD | -0.06 | 0.08 |
| Stochastic Oscillator | 0.00 | 75.54 |
Price Performance
Historical ComparisonAbout ZNB Zeta Network Group Class A Ordinary Shares
Zeta Network Group is an entertainment technology company with a network that focuses on the application of technology and artificial intelligence in the entertainment industry. It provides online entertainment performances and online education through its wholly-owned subsidiaries Color Metaverse and CACM. The curriculum developed by the company includes music, sports, animation, painting and calligraphy, film and television, and life skills, covering various aspects of entertainment, sports, and culture.
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.